Kezar Life Sciences, Inc. financial data

Symbol
KZR on Nasdaq
Industry
Pharmaceutical Preparations
Location
4000 Shoreline Court, Suite 300, South San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.35 K % -51.2%
Debt-to-equity 15.9 % +70.3%
Return On Equity -50.4 % -86.6%
Return On Assets -43.4 % -76%
Operating Margin -1.59 K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72.8 M shares +2.82%
Common Stock, Shares, Outstanding 72.8 M shares +2.8%
Entity Public Float 173 M USD -68.6%
Common Stock, Value, Issued 73 K USD +2.82%
Weighted Average Number of Shares Outstanding, Basic 72.8 M shares +0.65%
Weighted Average Number of Shares Outstanding, Diluted 72.8 M shares +0.65%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7 M USD
Research and Development Expense 84.6 M USD +44.8%
General and Administrative Expense 26.9 M USD +25.4%
Operating Income (Loss) -111 M USD -38.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -101 M USD -36.2%
Earnings Per Share, Basic -1.39 USD/shares -31.1%
Earnings Per Share, Diluted -1.39 USD/shares -31.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33 M USD -8.57%
Marketable Securities, Current 147 M USD -33.8%
Accounts Receivable, after Allowance for Credit Loss, Current 7 M USD
Other Assets, Current 935 K USD +14.3%
Assets, Current 186 M USD -30%
Property, Plant and Equipment, Net 3.65 M USD -21.6%
Operating Lease, Right-of-Use Asset 4.36 M USD -52.6%
Other Assets, Noncurrent 5.5 M USD +8.12%
Assets 199 M USD -29.9%
Accounts Payable, Current 5.06 M USD +22.3%
Employee-related Liabilities, Current 1.71 M USD +14.6%
Accrued Liabilities, Current 6.66 M USD -2.52%
Liabilities, Current 16.2 M USD +18.4%
Operating Lease, Liability, Noncurrent 5.02 M USD -38.4%
Liabilities 30 M USD -5.31%
Accumulated Other Comprehensive Income (Loss), Net of Tax -355 K USD +32.1%
Retained Earnings (Accumulated Deficit) -372 M USD -37.4%
Stockholders' Equity Attributable to Parent 169 M USD -33%
Liabilities and Equity 199 M USD -29.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.9 M USD -9.6%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 20.4 M USD +24.5%
Common Stock, Shares Authorized 250 M shares +100%
Common Stock, Shares, Issued 72.8 M shares +2.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.46 M USD +43.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 33 M USD -8.57%
Interest Paid, Excluding Capitalized Interest, Operating Activities 336 K USD +8.39%
Deferred Tax Assets, Valuation Allowance 82.5 M USD +44.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 83.8 M USD +41.2%
Operating Lease, Liability 8.15 M USD -24.7%
Depreciation 1.1 M USD +10%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -101 M USD -36.4%
Lessee, Operating Lease, Liability, to be Paid 9.37 M USD -28.8%
Property, Plant and Equipment, Gross 9.33 M USD -1.94%
Operating Lease, Liability, Current 3.13 M USD +17.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.06 M USD +3.49%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.92 M USD +3.32%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.22 M USD -48.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.39 M USD -65.8%
Deferred Tax Assets, Operating Loss Carryforwards 43 M USD +13.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 4.07 M USD +61.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 347 K USD +23.1%
Operating Lease, Payments 2.67 M USD +97.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 260 K USD +0.39%
Deferred Tax Assets, Net of Valuation Allowance 1.28 M USD -45.9%
Share-based Payment Arrangement, Expense 17.3 M USD +14.1%
Interest Expense 1.58 M USD +21.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%